Approval · Notice of Compliance 2962 · 1998
HYDRALAZINE: Notice of Compliance 2962
Issued November 27, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2962
- Date
- November 27, 1998
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Revised product monograph
- Therapeutic class
- Antihypertensive agent
- Canadian reference product
- HYDRALAZINE (Apotex Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYDRALAZINE | Not yet assigned | — |
Medicinal ingredients
- HYDRALAZINE 10 MG per TAB
- HYDRALAZINE 25 MG per TAB
- HYDRALAZINE 50 MG per TAB